Layout Image

News

January 2018 Press Release

Fabre-Kramer Partners with Mission Pharmacal for Future Commercial Manufacture of Novel Mechanism Antidepressant Travivo™ (Gepirone ER) Tablets HOUSTON, Jan. 03, 2018 (View release on GlobeNewswire.com) -- Fabre-Kramer Pharmaceuticals, Inc.  (Fabre-Kramer) of...

October 2016 Press Release

Mental Health Survey Reveals Available Antidepressants Aggravate Sexual Dysfunction and Make Depression Worse Patient Experience Demonstrates Pressing Need for New Treatment Options WASHINGTON and HOUSTON, Oct. 13, 2016 (View release...

March 2016 Press Release

FDA Rules Favorably On Efficacy Of Travivo™ (Gepirone ER) For Treatment Of Major Depressive Disorder Office of New Drugs’ decision overturns previous position on Fabre-Kramer Pharmaceuticals’ antidepressant with novel mechanism...